Covid19 Clinical Trial - Is Adipose Tissue a Reservoir for SARS-Cov2

Updated 06/21/2024

Status Not yet recruiting

Clinical Trial Summary

Resident cells of human adipose tissue express ACE2 and DPP4, receptors for SARS-Cov2. The hypothesis is that the virus may enter and spread in fat depots.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Covid-19 Patients

Clinical Trial Details

NCT number	NCT04427878
Study type	Interventional
Source	Centre Hospitalier Universitaire de Nice
Contact	Vanina OLIVERI, PM
Phone	0033 4 92 03 42 54
Email	oliveri.v@chu-nice.fr
Status	Not yet recruiting
Phase	N/A
Start date	July 1, 2020
Completion date	July 9, 2021

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT04592835` - To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003	Phase 1
	Not yet recruiting	`NCT05083104` - Assessment of the Natural Anticoagulant Profile in Patients With COVID-19
	Completed	`NCT05162534` - Independent Predictors on Clinical Outcomes in SARS-CoV2 Patients
	Completed	`NCT04853979` - Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure	N/A
	Completed	`NCT05369676` - To Evaluate SSD8432/ Ritonavir in Adults With COVID-19	Phase 1/Phase 2
	Completed	`NCT05901337` - Cupping Therapy on Immune System in Post Covid -19	N/A
	Recruiting	`NCT06349720` - Investigating Long-term Health Effects and Complications in COVID-19 Recoveries
	Completed	`NCT04407130` - Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.	Phase 2
	Terminated	`NCT04541485` - To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)	Phase 1
	Withdrawn	`NCT04374903` - Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients	N/A